Sodium Sulfacetamide 10% - Sulfur 5% Cleanser
Subpotent drug
Most common reason: Wrong potency / content (4 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Sulfacetamide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Subpotent drug
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
CGMP Deviations
CGMP Deviations
Subpotency: one product for active ingredient assay and another one for preservative assay
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lack of Assurance of Sterility
Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility: There are also CGMP Deviations.
Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability
Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.
Microbial Contamination of Non-Sterile Products: Product failed USP Microbial Limits Test.
Microbial Contamination of Non-Sterile Products: Product failed USP Microbial Limits Test.
Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.